Moreover, we used the GnRH agonist trigger for donors to minimize the risk of ovarian hyperstimulation syndrome, as used in some studies (17, 18), while in other studies the trigger was performed with HCG (2) or by HCG and triptorelin (14). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.